Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014
Örebro Univ, Sch Med Sci, Dept Resp Med, Örebro, Sweden.
Örebro Univ, Sch Med Sci, Örebro, Sweden.
Örebro Univ, Sch Med Sci, Örebro, Sweden.
Örebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Örebro, Sweden.; Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.; UCL, Dept Epidemiol & Publ Hlth, London, England.
Show others and affiliations
2017 (English)In: European Clinical Respiratory Journal, ISSN 2001-8525, Vol. 4, no 1, article id 1409060Article in journal (Refereed) Published
Abstract [en]

Introduction: The aim was to investigate how the pattern of pharmacological treatment in Swedish patients with chronic obstructive pulmonary disease (COPD) has changed over a decade, and to identify factors associated with treatment.

Methods: Data on patient characteristics and pharmacological treatment were collected using questionnaires from two separate cohorts of randomly selected primary and secondary care patients with a doctor’s diagnosis of COPD in central Sweden, in 2005 (n = 1111) and 2014 (n = 1329). Cross-tabulations and chi-square tests were used to compare maintenance treatment in 2005 and 2014, and to investigate the distribution of treatment by the 2017 Global Initiative for Obstructive Lung Disease (GOLD) ABCD groups. Multinomial logistic regression was used to analyze associations with the major types of recommended treatments: bronchodilator therapy, combined long-acting beta-2-antagonists (LABA) + inhaled corticosteroids (ICS), and triple inhaled therapy.

Results: The proportion of patients with no maintenance treatment, with only LABA + ICS, and with sole ICS statistically significantly decreased (36 vs. 31%, 16 vs. 12% and 5 vs. 2%, respectively), and the proportion with triple inhaled therapy statistically significantly increased (29 vs. 40%). In 2014, triple inhaled therapy was the most common treatment in all GOLD groups except group A. In 2014, previous frequent exacerbations [OR (95% CI) 2.34 (1.62 to 3.36)], worse COPD Assessment Test score [1.07 (1.05 to 1.09)], female sex [2.13 (1.56 to 2.91)], and access to a specific responsible doctor [1.95 (1.41 to 2.69)] were associated with triple inhaled therapy. Current smoking [0.40 (0.28 to 0.57)] and overweight [0.62 (0.41 to 0.93)] were inversely associated with triple inhaled therapy.

Conclusions: Over the last decade, triple inhaled therapy has increased, and no maintenance treatment, ICS, or LABA + ICS has decreased. Triple inhaled therapy is the most common treatment and is associated with previous exacerbations, higher symptom level, female sex, and having a specific responsible doctor.

Place, publisher, year, edition, pages
2017. Vol. 4, no 1, article id 1409060
Keywords [en]
ICS, LABA, LAMA, bronchodilator therapy, frequent exacerbations GOLD 2017, symptoms, triple inhaled therapy
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:uu:diva-342408DOI: 10.1080/20018525.2017.1409060ISI: 000417152400001PubMedID: 29230274OAI: oai:DiVA.org:uu-342408DiVA, id: diva2:1184162
Available from: 2018-02-20 Created: 2018-02-20 Last updated: 2018-03-02Bibliographically approved

Open Access in DiVA

fulltext(1497 kB)6 downloads
File information
File name FULLTEXT01.pdfFile size 1497 kBChecksum SHA-512
a70d4a7640a498685fc5ed4121a84068060a5bb9b72dfd1bdd527b4b5998a7d626f44a9d9605d7716368b2386b0256c11e108e261692c43c3014ae5fdafec8b5
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ställberg, BjörnLisspers, KarinJanson, Christer
By organisation
Family Medicine and Preventive MedicineLung- allergy- and sleep research
In the same journal
European Clinical Respiratory Journal
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar
Total: 6 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 9 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf